Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04517565 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Longitudinal Neuroimaging in Sturge-Weber Syndrome

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study completion pushed from Jun 30, 2026 to Jun 30, 2027v8
  2. Trial status: Recruiting to Active, Not Recruiting
    • Study completion date: Feb 28, 2026 to Jun 30, 2026
    • Site details revised
    v7
  3. Primary and study completion dates: Feb 28, 2025 to Feb 28, 2026
    • Site contact updated
    v6
  4. 2 versions Re-verified since Apr 24, 2023, no change to tracked fieldsv4-v5
  5. Start date: Jun 1, 2020 to Mar 1, 2020v3
  6. Re-verified, no change to tracked fieldsv2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
In this project the accuracy of a novel, rapid magnetic resonance imaging (MRI) approach to detect brain abnormalities in patients with Sturge-Weber syndrome (SWS) will be tested; this new imaging approach, that can create multiple types of MR images in about 5 minutes, without contrast administration (and sedation even in young children), can be also readily applied in other pediatric brain disorders in the future. The investigators will also study how advanced MRI, including susceptibility-weighted and diffusion tensor imaging can detect detailed signs of brain vascular and neuronal reorganization that helps improve neurological and cognitive outcome of children and young adults with SWS, who could benefit from targeted interventions in the future to minimize neurocognitive deficits in affected patients. All enrolled subjects will undergo advanced brain MRI and neurocognitive evaluation to achieve these goals.
Trial Details
NCT Number NCT04517565
Lead Sponsor Wayne State University
Collaborators: National Institutes of Health (NIH)
Conditions
(from sponsor)		 Sturge-Weber Syndrome
Related terms Sturge-Weber Syndrome
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov